Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)

57.53
Delayed Data
As of Aug 07
 +1.45 / +2.59%
Today’s Change
8.51
Today|||52-Week Range
63.45
+429.25%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Arcturus Therapeutics Holdings Inc have a median target of 69.50, with a high estimate of 80.00 and a low estimate of 31.00. The median estimate represents a +20.81% increase from the last price of 57.53.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Arcturus Therapeutics Holdings Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.54
Sales
$4.4M
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 19.73%
 
 
 
 
 
 
Growthannually -13.23%
 
 
 
 
 
 

Sales

Growthquarterly 66.06%
 
 
 
 
 
 
Growthannually -30.11%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.